Introduction
Methods
Data source and study participants
Data acquisition and preprocessing
Model development and validation
Model visualization and feature identification
Follow-up data
Statistical analysis
Results
Study population
Training dataset | Testing dataset | ||||||||
---|---|---|---|---|---|---|---|---|---|
Overall | Control | PLN | P value | Overall | Control | PLN | P value | ||
n | 787 | 565 | 222 | 112 | 56 | 56 | |||
Echocardiograms | 902 | 565 | 337 | 112 | 56 | 56 | |||
Age (years) | 53.1 [39.4–63.8] | 55.6 [47.2–65.6] | 40.1 [26.9–54.7] | < 0.001 | 46.9 [34.5–57.0] | 48.5 [34.2–56.3] | 43.7 [34.5–57.4] | 1.000 | |
Male sex | 414 (52.6) | 310 (54.9) | 118 (53.2) | 0.257 | 43 (38.4) | 21 (37.5) | 22 (39.3) | 1.000 | |
Heart rate (bpm) | 61.5 ± 10.9 | 58.5 ± 9.6 | 66.4 ± 11.1 | < 0.001 | 66.6 ± 9.7 | 66.4 ± 9.7 | 66.9 ± 9.9 | 1.000 | |
Hypertension | 298 (37.9) | 298 (52.7) | 0 (0) | < 0.001 | 24 (21.4) | 24 (42.9) | 0 (0) | < 0.001 | |
Heart failure history | 27 (3.4) | 5 (0.9) | 22 (9.9) | < 0.001 | 8 (7.1) | 0 (0) | 8 (14.3) | 0.042 | |
LVEF (%) | 58.4 [54.1–62.0] | 59.6 [56.1–63.2] | 56.0 [50.0–60.0] | < 0.001 | 56.5 [52.4–60.8] | 58.8 [55.8–62.6] | 54.0 [46.5–60.0] | < 0.001 | |
GLS (%) | 18.8 ± 3.1 | 19.3 ± 2.3 | 17.9 ± 3.9 | < 0.001 | 18.4 ± 3.8 | 19.7 ± 2.2 | 17.1 ± 4.6 | 0.003 |
Performance of deep learning algorithm
Feature identification
Clinical cluster characteristics
Overall | O | A | B | C | D | P value | |
---|---|---|---|---|---|---|---|
n | 278 | 27 | 84 | 45 | 67 | 55 | |
Patient characteristics | |||||||
Age (years) | 41.4 [28.6–54.8] | 36.5 [27.4–46.7] | 40.0 [23.8–52.5] | 45.7 [33.5–63.6] | 36.1 [24.0–44.4] | 53.6 [42.9–61.1] | < 0.001 |
Male sex | 126 (45.3) | 15 (55.6) | 31 (36.9) | 19 (42.2) | 33 (49.3) | 28 (50.9) | 1.0 |
Proband | 49 (17.6) | 0 (0) | 12 (14.3) | 2 (4.4) | 9 (13.4) | 26 (47.3) | < 0.001 |
Presymptomatic | 139 (50.0) | 22 (81.5) | 47 (56.0) | 28 (62.2) | 41 (61.2) | 1 (1.8) | < 0.001 |
History of heart failure | 30 (10.8) | 0 (0) | 3 (3.6) | 2 (4.4) | 3 (4.5) | 22 (40.0) | < 0.001 |
History of VA | 95 (34.2) | 4 (14.8) | 22 (26.2) | 9 (20.0) | 15 (22.4) | 45 (81.8) | < 0.001 |
History of sustained VA | 42 (15.2) | 0 (0) | 7 (8.3) | 1 (2.2) | 4 (6.0) | 30 (54.5) | < 0.001 |
ICD implanted | 58 (21.0) | 1 (3.7) | 11 (13.3) | 2 (4.4) | 8 (11.9) | 36 (66.7) | < 0.001 |
ACM diagnosis | 50 (18.5) | 0 (0) | 11 (13.8) | 8 (17.8) | 6 (9.1) | 25 (48.1) | < 0.001 |
DCM diagnosis | 42 (15.3) | 0 (0) | 5 (6.1) | 2 (4.4) | 4 (6.1) | 31 (57.4) | < 0.001 |
Echocardiogram characteristics | |||||||
Heart rate (bpm) | 66.2 ± 11.1 | 69.9 ± 12.2 | 68.6 ± 10.2 | 72.1 ± 10.1 | 59.9 ± 9.6 | 63.7 ± 10.0 | < 0.001 |
LVED volume (ml/m2) | 56.5 [48.8–64.4] | 53.7 [49.2–56.9] | 53.8 [46.9–61.7] | 49.4 [44.3–55.1] | 58.3 [52.9–65.8] | 75.3 [60.0–91.4] | < 0.001 |
LVES volume (ml/m2) | 24.3 [19.5–31.6] | 23.3 [19.0–24.9] | 22.5 [18.3–28.4] | 20.9 [18.6–23.3] | 24.7 [20.8–27.9] | 45.9 [34.6–63.5] | < 0.001 |
LVEF (%) | 56.0 [50.0–60.0] | 59.0 [56.0–61.0] | 57.0 [52.0–60.2] | 58.0 [53.0–61.0] | 57.0 [55.0–60.5] | 39.0 [29.0–46.0] | < 0.001 |
GLS (%) | 19.0 [16.5–20.5] | 19.4 [18.6–20.9] | 19.5 [17.9–20.4] | 19.6 [18.5–20.6] | 19.9 [18.4–21.4] | 12.1 [8.1–14.9] | < 0.001 |
RVED area (cm2/m2) | 10.0 [8.8–11.8] | 10.0 [9.5–10.9] | 9.7 [8.2–10.8] | 9.4 [8.2–11.1] | 9.6 [9.0–11.7] | 12.9 [10.2–15.6] | < 0.001 |
RVES area (cm2/m2) | 5.7 [4.6–7.2] | 5.5 [5.0–5.7] | 5.4 [4.2–6.8] | 5.2 [4.2–6.1] | 5.2 [4.5–6.8] | 9.2 [6.4–10.8] | < 0.001 |
FAC (%) | 41.6 ± 9.1 | 46.9 ± 4.1 | 43.3 ± 7.7 | 45.1 ± 7.8 | 44.2 ± 7.2 | 32.0 ± 8.7 | < 0.001 |
LVMD (ms) | 40.0 [30.0–55.0] | 31.0 [27.5–38.0] | 37.0 [29.0–43.0] | 38.0 [29.5–55.5] | 35.0 [27.0–48.0] | 62.5 [54.2–70.8] | < 0.001 |
E-wave velocity (cm/s) | 72.2 (19.3) | 71.4 (18.7) | 76.2 (21.1) | 64.0 (14.3) | 78.4 (16.7) | 63.1 (18.9) | 0.001 |
A-wave velocity (cm/s) | 52.0 (16.0) | 55.2 (14.3) | 53.4 (15.4) | 58.9 (15.7) | 46.1 (12.3) | 49.7 (20.3) | 0.024 |
Average e’ (cm/s) | 11.4 (4.0) | 11.8 (4.1) | 12.2 (3.9) | 10.6 (3.0) | 13.4 (3.6) | 6.9 (2.0) | < 0.001 |
E/e’ | 6.9 (2.7) | 6.3 (1.3) | 6.6 (2.3) | 6.4 (1.7) | 6.4 (2.9) | 9.2 (3.5) | < 0.001 |
LAVI (ml/m2) | 30.9 (9.5) | 27.6 (7.1) | 29.2 (6.9) | 29.0 (7.1) | 29.1 (8.5) | 39.1 (12.4) | < 0.001 |
Other clinical investigations | |||||||
Inferolateral T-wave inversion | 67 (24.1) | 2 (7.4) | 18 (21.4) | 11 (24.4) | 14 (20.9) | 22 (40.0) | 0.391 |
Low QRS voltage | 85 (31.6) | 3 (11.1) | 15 (18.3) | 8 (18.2) | 24 (38.1) | 35 (66.0) | < 0.001 |
PVC amount (per 24 h) | 178.0 [4.0–1574.0] | 11.5 [2.5–151.5] | 95.0 [3.8–1041.2] | 145.0 [3.0–1172.0] | 41.5 [2.0–639.2] | 2185.0 [1099.8–5065.0] | < 0.001 |